Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
Already Have An Account? Log in Now
Nutritional Considerations With Antiobesity Medications
abstract
This abstract is available on the publisher's site.
Access this abstract nowThe improved efficacy and generally favorable safety profile of recently approved and emerging antiobesity medications (AOMs), which result in an average weight reduction of ≥15%, represent significant advancement in the treatment of obesity. This narrative review aims to provide practical evidence-based recommendations for nutritional assessment, management, and monitoring of patients treated with AOMs. Prior to treatment, clinicians can identify preexisting nutritional risk factors and counsel their patients on recommended intakes of protein, dietary fiber, micronutrients, and fluids. During treatment with AOMs, ongoing monitoring can facilitate early recognition and management of gastrointestinal symptoms or inadequate nutrient or fluid intake. Attention should also be paid to other factors that can impact response to treatment and quality of life, such as physical activity and social and emotional health. In the context of treatment with AOMs, clinicians can play an active role in supporting their patients with obesity to improve their health and well-being and promote optimal nutritional and medical outcomes.
Additional Info
Disclosure statements are available on the authors' profiles:
Nutritional considerations with antiobesity medications
Obesity 2024 Jun 10;[EPub Ahead of Print], JP Almandoz, TA Wadden, C Tewksbury, CM Apovian, A Fitch, JD Ard, Z Li, J Richards, WS Butsch, I Jouravskaya, KS Vanderman, LM NeffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This comprehensive review provides guidance on dietary recommendations for patients taking emerging antiobesity medications (AOM), which show an efficacy of ≥15% average weight reduction. The recommendations are based on evidence pertaining to general healthy dietary patterns, bariatric surgery, and low-calorie diets. The review emphasizes clinician identification of preexisting nutritional risk factors in their patients and counseling them on adequate intake of energy, protein, macronutrients, micronutrients, fiber, and fluids.
Energy requirements vary based on a variety of factors, including age, sex, body weight, and physical activity. In general, to achieve weight loss, it is recommended that women consume 1200 to 1500 kcal per day and men consume 1500 to 1800 kcal per day. Protein intake is very important during weight loss; a daily protein intake of 60 g to 75 g, or up to 1.5 g per kg of body weight is generally recommended. Meal replacement products such as bars or shakes can be used to increase protein consumption, especially if appetite decreases as a result of AOM. Severe carbohydrate restriction is not necessary, as it can limit the intake of important nutritional elements such as vegetables, fruits, and whole grains. However, if a low carbohydrate diet is preferred, ample hydration with greater than 2 L per day of fluid intake with consumption of vegetables and fruits containing high amounts of micronutrients and fiber is recommended. Adequate fiber and fluid intake also help alleviate constipation that may occur in patients taking AOM. Fiber intake of 21 g to 25 g per day for women and 30 g to 38 g per day for men is recommended; this can be achieved by taking fiber supplements if one’s diet is inadequate in reaching the recommended fiber intake goal.
Although the evidence guiding intake of dietary fat is limited, foods rich in n-3 polyunsaturated fatty acids, n-6 polyunsaturated fatty acids, and monounsaturated fatty acids should be prioritized. These fatty acids can be found in nuts, seeds, vegetable oils, and fish. In addition, multivitamin supplementation and consumption of foods rich in potassium, calcium, vitamin D, vitamin B12, and iron is recommended. This is especially important in patients who have had malabsorptive gastrointestinal tract disorders or a history of malabsorptive bariatric surgery who have increased risk of fat-soluble vitamin (vitamins A, D, E, and K) deficiency. Careful assessment of patient history, risk factors for nutritional deficiency, and follow-up assessment of nutritional status can help optimize the nutritional and health outcomes of patients on AOM.